Only about one-fifth of the S&P 500 have so far reported second-quarter results, but at least five major talking points have emerged — some quite surprising — since earnings season Read more
Tag: Healthcare
Here are 5 things we’ve learned so far from earnings season
Only about one-fifth of the S&P 500 have so far reported second-quarter results, but at least five major talking points have emerged — some quite surprising — since earnings season Read more
Do kids still get polio vaccines? Is polio airborne? What you need to know
The New York health department reported the country’s first case of polio in almost a decade on Thursday, which has sparked plenty of questions about whether polio was eradicated, who Read more
Bavarian Nordic’s smallpox vaccine recommended for use against monkeypox in Europe
Bavarian Nordic A/S said Friday that it has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency, recommending that marketing authorization Read more
Roche backs 2022 outlook as profit climbs, boosted by diagnostics sales
Roche Holding AG said Thursday that profit for the first half of the year increased as sales grew, mainly driven by the diagnostics division. The Swiss pharmaceutical company ROG, -0.64% Read more
Bernstein still sees more pain ahead for stocks, until capitulation triggers bonafide rally next year
How bad is the mood out there right now? Try max bearish. So said Bank of America’s latest fund manager survey on Tuesday that showed expectations for profits and growth Read more
Novartis sales and profit drop, but backs 2022 guidance
Corrections & Amplifications This headline was corrected at 0516 GMT becuase the core oper income was misstated as $2.23B. Novartis AG said its sales and profit fell in the second Read more
Dow Jones Newswires: Novartis sales and profit drop, but backs 2022 guidance
The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from $2.89 billion a year earlier.
Celcuity stock soars after hours on breakthrough therapy designation for cancer drug
Shares of Celcuity Inc. CELC were up 17% at $10.80 after hours as the U.S. Food and Drug Administration granted Breakthrough Therapy designation for a cancer drug. The designation is Read more
GE to name its power business GE Vernova after split off
GE Vernova will be the name of General Electric Co.’s power business when it splits off from the company in 2024. The new name, GE said, is a mashup of Read more